Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Mar;10(3):FD01-2.
doi: 10.7860/JCDR/2016/17768.7404. Epub 2016 Mar 1.

Metolazone Associated Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap

Affiliations
Case Reports

Metolazone Associated Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap

Prabhat Kumar et al. J Clin Diagn Res. 2016 Mar.

Abstract

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are severe mucocutaneous disease with high mortality rate. It is characterised by severe necrosis and detachment of the epidermis. Drugs are the most common triggering agent for SJS/TEN. These are commonly reported with the use of aromatic antiepileptics, antiretrovirals, allopurinol, NSAID'S and sulfonamide antibiotics. Non antibiotic sulfonamides rarely cause SJS/TEN. Metolazone is a well known diuretic and is extensively used by clinicians. Although this drug is in market for last several decades, no case of SJS/TEN has been reported till date. We report a rare case of metolazone induced SJS/TEN overlap in a 55-year-old lady.

Keywords: Naranjo Probability Scale; SCORTEN score; Thiazide diuretic.

PubMed Disclaimer

Figures

[Table/Fig-1]:
[Table/Fig-1]:
Maculo-papular rash present over lower abdomen with few blister formation.
[Table/Fig-2]:
[Table/Fig-2]:
Extensive skin excoriation with ulceration over lower back.

Similar articles

Cited by

References

    1. Tomasini C, Derlino F, Quaglino P, Caproni M, Borroni G. From erythema multiforme to toxic epidermal necrolysis. Same spectrum or different diseases? G Ital Dermatol. Venereol. 2014;149(2):243–61. - PubMed
    1. Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011;7(6):803–13. - PubMed
    1. Rzany B, Mockenhaupt M, Baur S, Schröder W, Stocker U, Mueller J, et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. J Clin Epidemiol. 1996;49(7):769–73. - PubMed
    1. Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013;69(2):173. - PubMed
    1. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5:39. - PMC - PubMed

Publication types

LinkOut - more resources